FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002165029> ?p ?o ?g. }

• W2002165029 endingPage "155" @default.
• W2002165029 startingPage "151" @default.
• W2002165029 abstract "OBJECTIVE--To investigate whether plaque rupture and thrombosis have a role in silent ischaemia as well as in unstable angina. DESIGN--Prospective analysis of the results of haemostatic diagnostic tests at the moment of developing silent ischaemia at rest. SETTING--Coronary care unit. PATIENTS--22 patients with acute myocardial infarction, 12 patients with symptomatic angina (unstable angina), and 10 normal volunteers (control group). INTERVENTIONS--Continuous cardiac monitoring detected 15 asymptomatic episodes (silent ischaemia) in 6 patients with unstable angina. Blood samples were obtained at admission and when an asymptomatic alteration was detected and 10 minutes later. MAIN OUTCOME MEASURES--Comparisons of concentrations of tissue plasminogen activator, urokinase type plasminogen activator, tissue plasminogen activator inhibitor-1, cross-linked fibrin degradation products, von Willebrand factor, and thrombin-antithrombin III complexes in patients and controls at admission; same comparisons in patients with silent ischaemia at the start of an episode and 10 minutes later. RESULTS--Tissue plasminogen activator concentrations were raised at admission in patients with acute myocardial infarction (mean (SD) 14.2 (6) ng/ml) and in patients with unstable angina (10.1 (2.5) ng/ml) in comparison with controls (5.1 (2.7) ng/ml, p < 0.01 and < 0.05 respectively). There was no differences between the two groups of patients, however. Similar results were observed at the start of a silent ischaemic episode (9.8 (1.9) ng/ml) and 10 minutes later (10.5 (2.9) ng/ml) compared with controls (p < 0.05). Tissue plasminogen activator inhibitor-1 concentrations were raised in patients with acute myocardial infarction (45.1 (15) ng/ml) compared with volunteers (20.6 (16) ng/ml, p < 0.01). In patients with silent ischaemia tissue plasminogen activator inhibitor-1 concentrations were slightly but not significantly increased. Concentrations of cross-linked fibrin degradation products (D dimer) increased during unstable angina (2150 (350) ng/ml) and silent ischaemia (2270 (450) ng/ml) compared with the concentrations in volunteers (340 (80) ng/ml) and patients with acute myocardial infarction (310 (120) ng/ml; p < 0.01). CONCLUSIONS--The results suggest that thrombosis mediates the pathophysiological mechanisms of silent ischaemia and unstable angina." @default.
• W2002165029 created "2016-06-24" @default.
• W2002165029 creator A5050878005 @default.
• W2002165029 creator A5054933132 @default.
• W2002165029 creator A5059785414 @default.
• W2002165029 creator A5061342072 @default.
• W2002165029 creator A5080382536 @default.
• W2002165029 date "1994-02-01" @default.
• W2002165029 modified "2023-10-16" @default.
• W2002165029 title "Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina." @default.
• W2002165029 cites W1969128729 @default.
• W2002165029 cites W1975952149 @default.
• W2002165029 cites W1984101828 @default.
• W2002165029 cites W1990986783 @default.
• W2002165029 cites W2001876252 @default.
• W2002165029 cites W2023791250 @default.
• W2002165029 cites W2037696550 @default.
• W2002165029 cites W2058400959 @default.
• W2002165029 cites W2079246457 @default.
• W2002165029 cites W2080686773 @default.
• W2002165029 cites W2085482583 @default.
• W2002165029 cites W2098177557 @default.
• W2002165029 cites W2110852564 @default.
• W2002165029 cites W2163940066 @default.
• W2002165029 cites W2313786688 @default.
• W2002165029 cites W2313927993 @default.
• W2002165029 cites W2314745108 @default.
• W2002165029 cites W2403871594 @default.
• W2002165029 cites W2409338767 @default.
• W2002165029 doi "https://doi.org/10.1136/hrt.71.2.151" @default.
• W2002165029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/483635" @default.
• W2002165029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8130023" @default.
• W2002165029 hasPublicationYear "1994" @default.
• W2002165029 type Work @default.
• W2002165029 sameAs 2002165029 @default.
• W2002165029 citedByCount "32" @default.
• W2002165029 countsByYear W20021650292012 @default.
• W2002165029 countsByYear W20021650292016 @default.
• W2002165029 countsByYear W20021650292021 @default.
• W2002165029 crossrefType "journal-article" @default.
• W2002165029 hasAuthorship W2002165029A5050878005 @default.
• W2002165029 hasAuthorship W2002165029A5054933132 @default.
• W2002165029 hasAuthorship W2002165029A5059785414 @default.
• W2002165029 hasAuthorship W2002165029A5061342072 @default.
• W2002165029 hasAuthorship W2002165029A5080382536 @default.
• W2002165029 hasBestOaLocation W20021650291 @default.
• W2002165029 hasConcept C126322002 @default.
• W2002165029 hasConcept C164705383 @default.
• W2002165029 hasConcept C2776572282 @default.
• W2002165029 hasConcept C2776825266 @default.
• W2002165029 hasConcept C2776892390 @default.
• W2002165029 hasConcept C2777260377 @default.
• W2002165029 hasConcept C2777785093 @default.
• W2002165029 hasConcept C2777798775 @default.
• W2002165029 hasConcept C2777910003 @default.
• W2002165029 hasConcept C2778425758 @default.
• W2002165029 hasConcept C2779581417 @default.
• W2002165029 hasConcept C2779679481 @default.
• W2002165029 hasConcept C2780868729 @default.
• W2002165029 hasConcept C500558357 @default.
• W2002165029 hasConcept C541997718 @default.
• W2002165029 hasConcept C71924100 @default.
• W2002165029 hasConceptScore W2002165029C126322002 @default.
• W2002165029 hasConceptScore W2002165029C164705383 @default.
• W2002165029 hasConceptScore W2002165029C2776572282 @default.
• W2002165029 hasConceptScore W2002165029C2776825266 @default.
• W2002165029 hasConceptScore W2002165029C2776892390 @default.
• W2002165029 hasConceptScore W2002165029C2777260377 @default.
• W2002165029 hasConceptScore W2002165029C2777785093 @default.
• W2002165029 hasConceptScore W2002165029C2777798775 @default.
• W2002165029 hasConceptScore W2002165029C2777910003 @default.
• W2002165029 hasConceptScore W2002165029C2778425758 @default.
• W2002165029 hasConceptScore W2002165029C2779581417 @default.
• W2002165029 hasConceptScore W2002165029C2779679481 @default.
• W2002165029 hasConceptScore W2002165029C2780868729 @default.
• W2002165029 hasConceptScore W2002165029C500558357 @default.
• W2002165029 hasConceptScore W2002165029C541997718 @default.
• W2002165029 hasConceptScore W2002165029C71924100 @default.
• W2002165029 hasIssue "2" @default.
• W2002165029 hasLocation W20021650291 @default.
• W2002165029 hasLocation W20021650292 @default.
• W2002165029 hasLocation W20021650293 @default.
• W2002165029 hasLocation W20021650294 @default.
• W2002165029 hasOpenAccess W2002165029 @default.
• W2002165029 hasPrimaryLocation W20021650291 @default.
• W2002165029 hasRelatedWork W1983857981 @default.
• W2002165029 hasRelatedWork W1984301102 @default.
• W2002165029 hasRelatedWork W2023724201 @default.
• W2002165029 hasRelatedWork W2033424220 @default.
• W2002165029 hasRelatedWork W2079749940 @default.
• W2002165029 hasRelatedWork W2334559892 @default.
• W2002165029 hasRelatedWork W2363390399 @default.
• W2002165029 hasRelatedWork W2385626111 @default.
• W2002165029 hasRelatedWork W2405273995 @default.
• W2002165029 hasRelatedWork W4210385419 @default.
• W2002165029 hasVolume "71" @default.
• W2002165029 isParatext "false" @default.
• W2002165029 isRetracted "false" @default.

• next